StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) income statement

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2024, quý kết thúc ngày Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex, Inc. income statement

Ratios

Latest available, balances at Dec 31, 2024

Profitability, TTM

Gross margin
–
Operating margin
-3117.3%
Net margin
-3100.5%
Return on equity, FY2024
–

Financial strength

Current ratio
0.50
Debt to equity
–
Debt to assets
1.0%
Cash to current liabilities
21.8%

Valuation

P/E ratio
–
Price to sales
5.36
Price to book
–
Dividend yield
–

See a number that looks wrong?